German adolescents (n= 123) without previous pertussis vaccination, no history of pertussis
and low IgG-anti-pertussis-toxin (PT) levels received one dose of the Tdap vaccine …

OBJECTIVE: Monitor the long-term immunogenicity of a single dose of acellular pertussis
vaccine in health-care workers. DESIGN: German health-care workers and child-care …

A new five-component acellular pertussis (AP) vaccine containing 10 µLg of pertussis toxoid,
S µg of filamentous hemagglutinin, 5 jµ of combined agglutinogens 2 and 3, and 3 µg of …

To assess the reactogenicity and immunogenicity of the Biken acellular pertussis vaccine
(Pa) following administration of a single vaccine dose to young adults with or without a …

In two double-blind, randomized, comparative studies involving a total of 218 children, an
acellular pertussis (DTPa) vaccine containing diphtheria and tetanus toxoids and pertussis …

235 healthy 10–12 years old school children were randomly immunized with either a
booster dose of diphtheria-tetanus-acellular pertussis (dTap) or diphtheria-tetanus (dT) …

Background. The recent introduction of acellular pertussis vaccines (Pa) offers the possibility
of booster doses in older children and adults. This can be conveniently accomplished by …

We compared the reactions and immunogenicity of DT acellular pertussis (DTaP) vaccines
containing pertussis toxoid (PT) and filamentous haemagglutinin (FHA)(2-component DTaP) …

In 2008, the number of pertussis cases increased substantially among Japanese
adolescents, despite high coverage with acellular pertussis vaccine (DTaP). This study …

Three hundred and nineteen adolescents aged 10–12 years who had been previously
vaccinated with five doses of acellular pertussis-containing vaccines received single doses …